Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
-
ElectroCore’s Truvaga™ Plus Wins Men’s Health Magazine Tech Award
-
American Public Education Reports Third Quarter 2024 Financial Results
-
V2X, INC. ANNOUNCES PROPOSED SECONDARY OFFERING OF COMMON STOCK
-
Voyager Reports Third Quarter 2024 Financial and Operating Results
-
Erasca Reports Third Quarter 2024 Business Updates and Financial Results
-
Perdoceo Education Corporation Reports Third Quarter and Year to Date 2024 Results
-
Direct Digital Holdings Reports Q3 2024 Financial Results
-
Skyworks Reports Q4 and Full Year FY24 Results
-
Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions
-
DAWSON GEOPHYSICAL REPORTS THIRD QUARTER 2024 RESULTS
-
Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024
-
Magnolia Oil & Gas Operating LLC Announces Pricing of Offering of $400 Million Senior Notes
-
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
-
Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
-
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
-
Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
-
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
-
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
-
Alliance Entertainment Reports First Quarter Fiscal Year 2025 Results
-
Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Xenon Reports Q3 2024 Financial Results and Business Update
-
Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates
-
4M Therapeutics Awarded $120,000 Grant from SynGAP Research Fund to Evaluate GSK3β Inhibition in Preclinical SYNGAP1-Related Disorders Research
-
Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference
-
ENGlobal Announces Third Quarter 2024 Financial and Operating Results
-
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
-
Infrasense Conducts Pavement Structural Capacity Testing in South Dakota
-
GINSMS Announces Financial Results for the Three and Nine Months Ended September 30, 2024
-
ATHLETICA SPORT SYSTEMS INC. UNVEILS NEW CRYSTAPLEX LIVE-LED DIGITAL DASHERBOARD SYSTEM
-
Smart Sand, Inc. Announces Third Quarter 2024 Results
-
Scientific Industries to Host Third Quarter 2024 Financial Results Investor Call on November 15, 2024
-
HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor
-
Morgan Wilshire Securities, Inc. Donates to St. Jude Children's Research Hospital
-
FiscalNote Reports Third Quarter 2024 Financial Results
-
Deltek Celebrates the 17th Annual MVP Award Winners at Deltek ProjectCon 2024
-
Goodwill of Colorado Announces New Recycling Partnership With O-I Glass to Celebrate “America Recycles Day”
-
Core Molding Technologies Announces Leadership Succession Plans for Next Chapter of Growth
-
FiscalNote Announces Leadership Succession Plan to Drive Next Phase of Growth
-
Kitepipe Launches AtomWatch v.2 with Enhanced Boomi Monitoring
-
Union Pacific Honors 16 Companies with Annual Sustainability Partner Award
-
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
-
Elastic Announces 100% OpenTelemetry Experience for Kubernetes with the OTel Operator
-
Align Technology Hosts the 2024 Invisalign™ Ortho Summit, Its Premier Education Event to Enhance Digital Practice Transformation and Treatment Experiences for Patients, Teams, and Practices
-
Insteel Industries Declares Regular Quarterly and Special Cash Dividends
-
Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference
-
Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Adult Fiction Debut From Children’s and Medical Author Features the City That Never Sleeps and a Mind in Turmoil Fighting for Peace
-
GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

